×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
×
Close
CN1699 Our Business - Guide for Agents
分类
Endocrinology, Metabolism & Nutrition
27852
Global Medical University
6067
Allergy
1885
Anatomy & Morphology
1685
Andrology
414
Anesthesia & Intensive Care
1408
Anesthesiology
6189
Audiology & Speech-Language Pathology
356
Behavioral Sciences
111
Biochemical Research Methods
8085
Biochemistry & Molecular Biology
33848
Biodiversity Conservation
366
Biology
9835
Biophysics
10757
Biotechnology & Applied Microbiology
9629
Cardiac & Cardiovascular Systems
35086
Cardiovascular & Respiratory Systems
1644
Cell & Tissue Engineering
766
Cell Biology
12153
Chemistry, Analytical
4646
Chemistry, Applied
12705
Chemistry, Medicinal
9566
Chemistry, Multidisciplinary
20833
Clinical Immunology & Infectious Disease
483
Clinical Medicine
9617
Clinical Neurology
18321
Clinical Psychology & Psychiatry
1675
Critical Care Medicine
3649
Dentistry, Oral Surgery & Medicine
15287
Dermatology
8008
Developmental Biology
7594
Ecology
655
Education, Scientific Disciplines
2191
Emergency Medicine
4685
Engineering, Biomedical
4139
Entomology
482
Environmental Medicine & Public Health
5403
Evolutionary Biology
288
Gastroenterology & Hepatology
13616
General & Internal Medicine
7948
Genetics & Heredity
17141
Geriatrics & Gerontology
5612
Gerontology
366
Health Care Sciences & Services
18048
Health Policy & Services
671
Hematology
5981
Immunology
28892
Infectious Diseases
15623
Integrative & Complementary Medicine
3227
Medical Ethics
1286
Medical Informatics
2681
Medical Laboratory Technology
433
Medicine, General & Internal
49656
Medicine, Legal
591
Medicine, Research & Experimental
20719
Microbiology
26859
Mycology
0
Nanoscience & Nanotechnology
5982
Neuroimaging
1495
Neurology
5249
Neurosciences
45667
Nursing
10558
Nutrition & Dietetics
8568
Obstetrics & Gynecology
9284
Oncology
59148
Ophthalmology
11224
Optics
5213
Orthopedics
12938
Orthopedics, Rehabilitation & Sports Medicine
2047
Otolaryngology
1687
Otorhinolaryngology
5408
Parasitology
1155
Pathology
5545
Pediatrics
24149
Peripheral Vascular Disease
5255
Pharmacology & Pharmacy
40845
Pharmacology/Toxicology
14106
Physiology
9824
Polymer Science
684
Primary Health Care
907
Psychiatry
23040
Psychology
5691
Psychology, Applied
113
Psychology, Biological
389
Psychology, Clinical
894
Psychology, Developmental
235
Psychology, Educational
149
Psychology, Experimental
147
Psychology, Mathematical
0
Psychology, Multidisciplinary
1697
Psychology, Psychoanalysis
41
Psychology, Social
122
Public Health & Health Care Science
2416
Public, Environmental & Occupational Health
30671
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
14052
Radiology, Nuclear Medicine & Medical Imaging
8800
Rehabilitation
3235
Remote Sensing
0
Reproductive Biology
3328
Reproductive Medicine
1339
Research/Laboratory Medicine & Medical Technology
4498
Respiratory System
8220
Rheumatology
6726
Social Sciences, Biomedical
1314
Substance Abuse
2987
Surgery
38427
Toxicology
4718
Transplantation
953
Tropical Medicine
314
Urology & Nephrology
14803
Veterinary Sciences
35
Virology
2647
Zoology
0
渠道
DIABETES OBESITY & METABOLISM
293
NEJM Endocrinology
9
Medrxiv - Endocrinology Medrxiv
549
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
472
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
203
BIOLOGY OF SEX DIFFERENCES
233
BMJ OPEN DIABETES RESEARCH & CARE
414
BONE
0
CALCIFIED TISSUE INTERNATIONAL
388
CARDIOVASCULAR DIABETOLOGY
819
CURRENT DIABETES REPORTS
151
CURRENT OBESITY REPORTS
136
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY
182
CURRENT OPINION IN LIPIDOLOGY
137
CURRENT OSTEOPOROSIS REPORTS
199
DIABETES
134
DIABETES & METABOLISM
217
DIABETES & METABOLISM JOURNAL
40
DIABETES CARE
194
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
1162
DIABETES RESEARCH AND CLINICAL PRACTICE
0
DIABETES-METABOLISM RESEARCH AND REVIEWS
105
DIABETIC MEDICINE
215
DIABETOLOGIA
626
ENDOCRINE
919
ENDOCRINE PATHOLOGY
152
ENDOCRINE PRACTICE
782
EUROPEAN THYROID JOURNAL
19
FRONTIERS IN ENDOCRINOLOGY
7006
HORMONES AND BEHAVIOR
378
JOURNAL OF BONE AND MINERAL RESEARCH
173
JOURNAL OF DIABETES
101
JOURNAL OF DIABETES INVESTIGATION
260
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
787
JOURNAL OF HUMAN NUTRITION AND DIETETICS
112
JOURNAL OF NEUROENDOCRINOLOGY
115
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
252
LANCET DIABETES & ENDOCRINOLOGY
16
METABOLISM-CLINICAL AND EXPERIMENTAL
18
MOLECULAR METABOLISM
625
NATURE REVIEWS ENDOCRINOLOGY
503
NEUROENDOCRINOLOGY
149
NUTRITION & DIABETES
145
OBESITY
151
OBESITY REVIEWS
130
PEDIATRIC DIABETES
87
PSYCHONEUROENDOCRINOLOGY
0
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
34
ARCHIVES OF ENDOCRINOLOGY METABOLISM
0
CLINICAL ENDOCRINOLOGY
179
DIABETES & VASCULAR DISEASE RESEARCH
16
DIABETOLOGY & METABOLIC SYNDROME
626
ENDOCRINOLOGIA DIABETES Y NUTRICION
407
GENERAL AND COMPARATIVE ENDOCRINOLOGY
0
INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM
177
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
139
JOURNAL OF CLINICAL DENSITOMETRY
241
JOURNAL OF DIABETES AND ITS COMPLICATIONS
475
NEUROIMMUNOMODULATION
83
OBESITY FACTS
160
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
444
WORLD REVIEW OF NUTRITION AND DIETETICS
30
HORMONE AND METABOLIC RESEARCH
365
NEUROPEPTIDES
159
THYROID RESEARCH
97
REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL
44
BRITISH JOURNAL OF DIABETES
135
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES
20
CLINICAL OBESITY
44
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM
34
DIABETOLOGY INTERNATIONAL
220
JOURNAL OF DIABETES AND METABOLIC DISORDERS
593
JOURNAL OF DIABETOLOGY
126
JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES
222
OBESITY SCIENCE & PRACTICE
87
PITUITARY
299
OSTEOPOROSIS INTERNATIONAL
671
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
253
DIABETES THERAPY
495
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM
285
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES
366
METABOLIC BRAIN DISEASE
568
SCI时时刷
search
全部
推荐
+
Effects of a six‐month low‐carbohydrate diet on glycemic control, body composition and cardiovascular risk factors in patients with type 2 diabetes: an open‐label RCT
Abstract Aims To investigate the efficacy and safety of a non-calorie-restricted low-carbohydrate diet (LCD) on glycemic c...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Dulaglutide and Incident Atrial Fibrillation or Flutter in patients with type 2 Diabetes; a post‐hoc analysis from the REWIND Randomized Trial
Abstract Aims Diabetes mellitus is an independent risk factor for atrial fibrillation or atrial flutter (atrial arrythmia,...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Reduction of clinically important low glucose excursions with a long‐term implantable continuous glucose monitoring (CGM) system in adults with type 1 diabetes prone to hypoglycemia. France Adoption randomized clinical trial
Abstract Aim This trial assessed the outcomes on glucose control of the implantable Eversense real-time continuous glucose...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Acute effects of linagliptin on intact and total GLP‐1 and GIP levels in insulin‐dependent type 2 diabetic patients with and without moderate renal impairment
Abstract Aims Impaired renal function is a frequent complication in patients with type 2 diabetes mellitus (T2DM). The goa...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Understanding the clinical implications of differences between GMI and HbA1c
Abstract Laboratory measured glycosylated hemoglobin (HbA1c) is the gold standard for assessing glycemic control in people...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Quételet (Body Mass) Index and Effects of Dapagliflozin in CKD
Abstract Aims This post-hoc analysis of DAPA-CKD (NCT03036150) assessed the effects of dapagliflozin in patients with chro...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and safety of high‐dose GLP‐1, GLP‐1/GIP and GLP‐1/glucagon receptor agonists in type 2 diabetes
Abstract Background GLP-1 receptor agonists (GLP-1 RAs) have become agents of choice for people with type 2 diabetes (T2D)...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and safety of imeglimin add‐on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double‐blind, placebo‐controlled phase 3 trial with a 36‐week open‐label extension period
Abstract Aims To evaluate the efficacy and safety of imeglimin for up to 52 weeks as combination therapy with insul...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Combined SGLT‐2 and ACE inhibition upregulates the renin‐angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double‐blind, placebo‐controlled exploratory trial
ABSTRACT Aims Sodium glucose co-transporter-2 inhibitors (SGLT-2i) improve cardiorenal outcomes in chronic kidney disease ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: a post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials
ABSTRACT Aims Bempedoic acid inhibits ATP-citrate lyase (ACL), an enzyme in the cholesterol synthesis pathway. Mendelian r...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin‐R with the US‐licensed Humulin® R formulation in healthy subjects: Results from the RHINE‐1 (Recombinant Human INsulin Equivalence‐1) study
Abstract Aims The aim of RHINE-1, a double-blind, randomized, two-treatment, two-period, two-sequence crossover study, was...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Elevated liver enzymes and comorbidities in type 2 diabetes: A multicentre analysis of 51 645 patients from the Diabetes Prospective Follow‐up (DPV) database
Abstract Aim To assess the prevalence of elevated liver enzymes and associated diabetes-related comorbidities in type 2 di...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Improving beta‐cell secretory function and glycaemia in young‐onset type 2 diabetes: A pilot, 12‐month, randomized trial of a novel, continuous glucose monitor‐guided, rapid treatment intensification strategy incorporating empagliflozin and liraglutide
1 BACKGROUND Young-onset type 2 diabetes (YT2D) is characterized by poorer glycaemic control, a higher ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Long‐term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52‐week, open‐label, multicentre phase 3 trial
Abstract Aim To evaluate the safety and efficacy of imeglimin for 52 weeks as monotherapy or combination therapy wi...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial
1 INTRODUCTION The prevalence of non-alcoholic fatty liver disease (NAFLD) is approximately 25% in both...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes
Abstract Aims The glucagon-like peptide-1 analogue, semaglutide, has been co-formulated with the absorption enhancer, sodi...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Pushing the limits of insulin delivery 100 years later: A Case Study of a Race Across Canada
This article has been accepted for publication and undergone full peer review but has not been through the co...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Real‐world data of 12‐month adjunct sodium‐glucose co‐transporter‐2 inhibitor treatment in type 1 diabetes from the German/Austrian DPV registry: Improved HbA1c without diabetic ketoacidosis
1 INTRODUCTION Sodium-glucose co-transporter-2 inhibitors (SGLT2is) represent a class of oral antidiabe...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Where can you wear your libre? Using the FreeStyle Libre Continuous Glucose Monitor on Alternative Sites
Abstract Aims Subcutaneous continuous glucose monitoring (CGMS) has transformed management of Type 1 diabetes (T1DM). The ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
SGLT‐2 inhibitor for type 1 diabetes ‐ not any more?
This article has been accepted for publication and undergone full peer review but has not been through the co...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
The relationship between hypoglycaemia and glucose variability in type 1 diabetes
1 INTRODUCTION Hypoglycaemia is a considerable barrier to intensified blood glucose management in type ...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Disparity in the rural‐urban distribution of clinical trial sites used in studies cited by diabetes treatment guidelines
1 INTRODUCTION The prevalence of diabetes and the associated complications are higher in rural areas in...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials
Abstract Aim To investigate the association between treatment with dulaglutide and glycaemic variability (GV) in adult pat...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis
Abstract Aims To conduct a pooled analysis to assess the performance of intermittently scanned continuous glucose monitori...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Metabolically healthy obesity and cardiovascular events: A risk of obesity
Corresponding Author Tomoyuki Kawada MD & PhD Departme...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes and Non‐Alcoholic Fatty Liver Disease: A Multicenter, Double‐blind, Randomized, Comparative trial
Corresponding Author Byung-Wan Lee MD, PhD Division of End...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Cost‐Effectiveness of Second‐Line Empagliflozin versus Liraglutide for Type 2 Diabetes in the United States
Abstract Aims To estimate the cost-effectiveness of sequential use of the sodium-glucose co-transporter 2 inhibitor empagl...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects
Corresponding Author Soo Lim MD Department of Internal Med...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease
Abstract Aims The sodium-glucose co-transporter-2 inhibitor empagliflozin reduced the total burden of cardiovascular morta...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: A population‐based analysis between 2010‐2020
Abstract Aim To examine trends in basal insulin prescribing in older adults with CKD. Materials and methods We conducted a...
Diabetes Obesity & Metabolism
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin